Integrated analysis of gene network in childhood leukemia from microarray and pathway databases

Amphun Chaiboonchoe, Sandhya Samarasinghe, Don Kulasiri, Kourosh Salehi-Ashtiani

Research output: Contribution to journalArticle

Abstract

Glucocorticoids (GCs) have been used as therapeutic agents for children with acute lymphoblastic leukaemia (ALL) for over 50 years. However, much remains to be understood about the molecular mechanism of GCs actions in ALL subtypes. In this study, we delineate differential responses of ALL subtypes, B- and T-ALL, to GCs treatment at systems level by identifying the differences among biological processes, molecular pathways, and interaction networks that emerge from the action of GCs through the use of a selected number of available bioinformatics methods and tools. We provide biological insight into GC-regulated genes, their related functions, and their networks specific to the ALL subtypes. We show that differentially expressed GC-regulated genes participate in distinct underlying biological processes affected by GCs in B-ALL and T-ALL with little to no overlap. These findings provide the opportunity towards identifying new therapeutic targets.

Original languageEnglish (US)
Article number278748
JournalBioMed Research International
Volume2014
DOIs
StatePublished - Jan 1 2014

Fingerprint

Gene Regulatory Networks
Microarrays
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Glucocorticoids
Leukemia
Genes
Databases
Biological Phenomena
Bioinformatics
Computational Biology
Therapeutics

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)
  • Medicine(all)

Cite this

Integrated analysis of gene network in childhood leukemia from microarray and pathway databases. / Chaiboonchoe, Amphun; Samarasinghe, Sandhya; Kulasiri, Don; Salehi-Ashtiani, Kourosh.

In: BioMed Research International, Vol. 2014, 278748, 01.01.2014.

Research output: Contribution to journalArticle

@article{9ca998a1e3e14370ad6db26ef822fc68,
title = "Integrated analysis of gene network in childhood leukemia from microarray and pathway databases",
abstract = "Glucocorticoids (GCs) have been used as therapeutic agents for children with acute lymphoblastic leukaemia (ALL) for over 50 years. However, much remains to be understood about the molecular mechanism of GCs actions in ALL subtypes. In this study, we delineate differential responses of ALL subtypes, B- and T-ALL, to GCs treatment at systems level by identifying the differences among biological processes, molecular pathways, and interaction networks that emerge from the action of GCs through the use of a selected number of available bioinformatics methods and tools. We provide biological insight into GC-regulated genes, their related functions, and their networks specific to the ALL subtypes. We show that differentially expressed GC-regulated genes participate in distinct underlying biological processes affected by GCs in B-ALL and T-ALL with little to no overlap. These findings provide the opportunity towards identifying new therapeutic targets.",
author = "Amphun Chaiboonchoe and Sandhya Samarasinghe and Don Kulasiri and Kourosh Salehi-Ashtiani",
year = "2014",
month = "1",
day = "1",
doi = "10.1155/2014/278748",
language = "English (US)",
volume = "2014",
journal = "BioMed Research International",
issn = "2314-6133",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Integrated analysis of gene network in childhood leukemia from microarray and pathway databases

AU - Chaiboonchoe, Amphun

AU - Samarasinghe, Sandhya

AU - Kulasiri, Don

AU - Salehi-Ashtiani, Kourosh

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Glucocorticoids (GCs) have been used as therapeutic agents for children with acute lymphoblastic leukaemia (ALL) for over 50 years. However, much remains to be understood about the molecular mechanism of GCs actions in ALL subtypes. In this study, we delineate differential responses of ALL subtypes, B- and T-ALL, to GCs treatment at systems level by identifying the differences among biological processes, molecular pathways, and interaction networks that emerge from the action of GCs through the use of a selected number of available bioinformatics methods and tools. We provide biological insight into GC-regulated genes, their related functions, and their networks specific to the ALL subtypes. We show that differentially expressed GC-regulated genes participate in distinct underlying biological processes affected by GCs in B-ALL and T-ALL with little to no overlap. These findings provide the opportunity towards identifying new therapeutic targets.

AB - Glucocorticoids (GCs) have been used as therapeutic agents for children with acute lymphoblastic leukaemia (ALL) for over 50 years. However, much remains to be understood about the molecular mechanism of GCs actions in ALL subtypes. In this study, we delineate differential responses of ALL subtypes, B- and T-ALL, to GCs treatment at systems level by identifying the differences among biological processes, molecular pathways, and interaction networks that emerge from the action of GCs through the use of a selected number of available bioinformatics methods and tools. We provide biological insight into GC-regulated genes, their related functions, and their networks specific to the ALL subtypes. We show that differentially expressed GC-regulated genes participate in distinct underlying biological processes affected by GCs in B-ALL and T-ALL with little to no overlap. These findings provide the opportunity towards identifying new therapeutic targets.

UR - http://www.scopus.com/inward/record.url?scp=84900015223&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900015223&partnerID=8YFLogxK

U2 - 10.1155/2014/278748

DO - 10.1155/2014/278748

M3 - Article

C2 - 24822192

AN - SCOPUS:84900015223

VL - 2014

JO - BioMed Research International

JF - BioMed Research International

SN - 2314-6133

M1 - 278748

ER -